SLC5A2 and Insulin resistance: Several reports have suggested that in addition to its blood glucose-lowering effects, SGLT2 inhibitors exert various other effects such as lowering BP [5, 6], improving the serum lipid profile [7], decreasing body weight [6, 8], and improving insulin resistance [9].